New insights into Notch1 regulation of the PI3K–AKT–mTOR1 signaling axis: Targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

New insights into Notch1 regulation of the PI3K–AKT–mTOR1 signaling axis: Targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia

Published:2014-01 Issue:1 Volume:26 Page:149-161
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Hales Eric C.,Taub Jeffrey W.,Matherly Larry H.

Funder

Herrick Foundation

Wayne State University

Dale Meyer Endowment for Leukemia Research

Ring Screw Textron Endowed Chair for Pediatric Research

Publisher

Elsevier BV

Subject

Cell Biology

Reference199 articles.

1. Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

2. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia [see comments]

3. Recent Research Advances in Childhood Acute Lymphoblastic Leukemia

4. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia

5. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment;Frontiers in Pharmacology;2024-08-05

2. NOTCH1- and CD117-Positive Stem Cells in Human Endometriosis and Adenomyosis Lesions;Diagnostics;2024-07-30

3. Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study;Cancer;2024-05-04

4. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes;Modern Pathology;2024-05

5. Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia;Frontiers in Oncology;2024-02-20